Nath Bio-Genes

{
  "main_header": {
    "sid": 628630,
    "name": "Nath Bio-Genes",
    "stock_name": "Nath Bio-Genes",
    "full_name": "Nath Bio-Genes (India) Ltd",
    "name_url": "stocks-analysis/nath-bio-genes",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "147.48",
    "chg": -0.5,
    "chgp": "-0.34%",
    "dir": -1,
    "prev_price": "147.98",
    "mcapval": "279.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537291,
    "symbol": "NATHBIOGEN",
    "ind_name": "Other Agricultural Products",
    "ind_code": 107,
    "indexname": "",
    "isin": "INE448G01010",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "7.79 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nath-bio-genes-628630-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Nath Bio-Genes (India) Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-upgraded-to-sell-on-technical-improvements-and-valuation-appeal-3781070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NathBioGenesInd_mojoScore_3781070.png",
        "date": "2026-01-05 08:11:14",
        "description": "Nath Bio-Genes (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 January 2026, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but improved outlook amid mixed financial and market signals."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-3779836",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NathBioGenesInd_mojoScore_3779836.png",
        "date": "2026-01-03 10:10:34",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 January 2026, providing investors with the most recent and relevant data to assess the company's outlook."
      },
      {
        "title": "Nath Bio-Genes (India) Faces Challenging Market Assessment Amidst Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3766672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NathBioGenesInd_mojoScore_3766672.png",
        "date": "2025-12-23 08:45:09",
        "description": "Nath Bio-Genes (India), a player in the Other Agricultural Products sector, has experienced a shift in market evaluation driven by a combination of technical indicators, valuation metrics, financial trends, and broader market participation. This article analyses the factors influencing the recent revision in the company’s assessment, highlighting key data points and contextualising its performance against sector and market benchmarks."
      },
      {
        "title": "Why is Nath Bio-Genes falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nath-bio-genes-fallingrising-3749560",
        "imagepath": "",
        "date": "2025-12-06 01:25:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>On 05-Dec, Nath Bio-Genes closed at ₹142.45, down by ₹3.4 or 2.33%, marking a continuation of a downward trend that has persisted over the last four trading sessions. During this period, the stock has lost nearly 9.84% in value, hitting a fresh 52-week low of ₹140.1 intraday. This decline is further accentuated by the stock’s underperformance against its sector, lagging by 3.08% on the day. The weighted average price indicates that a significant volume of shares traded closer to the day’s low, signalling selling pressure among investors.</p>\n<p>Moreover, Nath Bio-Genes is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish sentiment prevailing..."
      },
      {
        "title": "Nath Bio-Genes (India) Stock Hits 52-Week Low at Rs.140.1 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-india-stock-hits-52-week-low-amidst-continued-downtrend-3749224",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NathBioGenesInd_priceRelatedfactors_3749224.png",
        "date": "2025-12-05 15:53:01",
        "description": "Nath Bio-Genes (India) has reached a fresh 52-week low of Rs.140.1, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s sector and financial metrics."
      },
      {
        "title": "Nath Bio-Genes (India) Stock Hits 52-Week Low at Rs.140.1 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-india-stock-hits-52-week-low-amidst-continued-downtrend-3749223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NathBioGenesInd_priceRelatedfactors_3749223.png",
        "date": "2025-12-05 15:52:59",
        "description": "Nath Bio-Genes (India) has reached a new 52-week low of Rs.140.1, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s financial and operational metrics."
      },
      {
        "title": "Nath Bio-Genes Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3741042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NathBioGenes_mojoScore_3741042.png",
        "date": "2025-12-02 10:09:46",
        "description": "Nath Bio-Genes has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. The company’s recent performance metrics and investor participation trends have contributed to this updated assessment, signalling caution for stakeholders in the Other Agricultural Products sector."
      },
      {
        "title": "Why is Nath Bio-Genes falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nath-bio-genes-fallingrising-3716327",
        "imagepath": "",
        "date": "2025-11-19 23:02:02",
        "description": "As of 19-Nov, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 160.65, which reflects a decrease of 3.0 points or 1.83%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.72% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance against the benchmark, the stock has shown negative returns over various periods, including a year-to-date decline of 14.66% compared to a 9.02% increase in the Sensex. There is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nBroader Market Context: In the context of the broader market, the Agri-Seeds sector has also seen a downturn, with a decline of 5.53%. While Nath Bio-Genes has outperformed its sector by 3.5% toda..."
      },
      {
        "title": "Nath Bio-Genes Q2 FY26: Seasonal Slump Masks Underlying Growth as Stock Struggles",
        "link": "https://www.marketsmojo.com/news/result-analysis/nath-bio-genes-q2-fy26-seasonal-slump-masks-underlying-growth-as-stock-struggles-3716634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NathBioGenesInd_quaterlyResult_3716634.png",
        "date": "2025-11-15 10:04:35",
        "description": "Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹320.00 crores, reported a consolidated net profit of ₹2.75 crores for Q2 FY26 (Jul-Sep'25), representing a sharp 92.62% quarter-on-quarter decline but a robust 147.75% year-on-year improvement. The dramatic sequential fall reflects the company's highly seasonal business model, where the first quarter typically captures the bulk of annual revenues during the peak agricultural season."
      }
    ],
    "total": 135,
    "sid": "628630",
    "stock_news_url": "https://www.marketsmojo.com/news/nath-bio-genes-india-628630"
  },
  "announcements": [
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding Related Party Transaction for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Other General Purpose",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding Investor Presentation on unaudited financial results for the period ended 30th sep 2019",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Investor Presentation",
      "datetime": "04-Nov-2019"
    },
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.'.",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Updates",
      "datetime": "30-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nath Bio-Genes (India) Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal

2026-01-05 08:11:14

Nath Bio-Genes (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 January 2026, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but improved outlook amid mixed financial and market signals.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-01-03 10:10:34

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 January 2026, providing investors with the most recent and relevant data to assess the company's outlook.

Read full news article

Nath Bio-Genes (India) Faces Challenging Market Assessment Amidst Mixed Financial and Technical Signals

2025-12-23 08:45:09

Nath Bio-Genes (India), a player in the Other Agricultural Products sector, has experienced a shift in market evaluation driven by a combination of technical indicators, valuation metrics, financial trends, and broader market participation. This article analyses the factors influencing the recent revision in the company’s assessment, highlighting key data points and contextualising its performance against sector and market benchmarks.

Read full news article

Why is Nath Bio-Genes falling/rising?

2025-12-06 01:25:11

Recent Price Movement and Market Performance

On 05-Dec, Nath Bio-Genes closed at ₹142.45, down by ₹3.4 or 2.33%, marking a continuation of a downward trend that has persisted over the last four trading sessions. During this period, the stock has lost nearly 9.84% in value, hitting a fresh 52-week low of ₹140.1 intraday. This decline is further accentuated by the stock’s underperformance against its sector, lagging by 3.08% on the day. The weighted average price indicates that a significant volume of shares traded closer to the day’s low, signalling selling pressure among investors.

Moreover, Nath Bio-Genes is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish sentiment prevailing...

Read full news article

Nath Bio-Genes (India) Stock Hits 52-Week Low at Rs.140.1 Amidst Prolonged Downtrend

2025-12-05 15:53:01

Nath Bio-Genes (India) has reached a fresh 52-week low of Rs.140.1, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s sector and financial metrics.

Read full news article

Nath Bio-Genes (India) Stock Hits 52-Week Low at Rs.140.1 Amidst Continued Downtrend

2025-12-05 15:52:59

Nath Bio-Genes (India) has reached a new 52-week low of Rs.140.1, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s financial and operational metrics.

Read full news article

Nath Bio-Genes Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-02 10:09:46

Nath Bio-Genes has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. The company’s recent performance metrics and investor participation trends have contributed to this updated assessment, signalling caution for stakeholders in the Other Agricultural Products sector.

Read full news article

Why is Nath Bio-Genes falling/rising?

2025-11-19 23:02:02

As of 19-Nov, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 160.65, which reflects a decrease of 3.0 points or 1.83%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.72% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance against the benchmark, the stock has shown negative returns over various periods, including a year-to-date decline of 14.66% compared to a 9.02% increase in the Sensex. There is no information available regarding positive or negative factors that could influence the stock's recent movement. Broader Market Context: In the context of the broader market, the Agri-Seeds sector has also seen a downturn, with a decline of 5.53%. While Nath Bio-Genes has outperformed its sector by 3.5% toda...

Read full news article

Nath Bio-Genes Q2 FY26: Seasonal Slump Masks Underlying Growth as Stock Struggles

2025-11-15 10:04:35

Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹320.00 crores, reported a consolidated net profit of ₹2.75 crores for Q2 FY26 (Jul-Sep'25), representing a sharp 92.62% quarter-on-quarter decline but a robust 147.75% year-on-year improvement. The dramatic sequential fall reflects the company's highly seasonal business model, where the first quarter typically captures the bulk of annual revenues during the peak agricultural season.

Read full news article

View All News